Glycol Chitosan-Poly(lactic acid) Conjugate Nanoparticles Encapsulating Ciprofloxacin: A Mucoadhesive, Antiquorum-Sensing, and Biofilm-Disrupting Treatment Modality for Bacterial Keratitis

ACS Appl Mater Interfaces. 2024 Apr 17;16(15):18360-18385. doi: 10.1021/acsami.3c18061. Epub 2024 Apr 4.

Abstract

Bacterial keratitis (BK) causes visual morbidity/blindness if not treated effectively. Here, ciprofloxacin (CIP)-loaded nanoparticles (NPs) using glycol chitosan (GC) and poly(lactic acid) (PLA) conjugate at three different ratios (CIP@GC(PLA) NPs (1:1,5,15)) were fabricated. CIP@GC(PLA) NPs (1:1) were more effective than other tested ratios, indicating the importance of optimal hydrophobic/hydrophilic balance for corneal penetration and preventing bacterial invasion. The CIP@GC(PLA) (NPs) (1:1) realized the highest association with human corneal epithelial cells, which were nonirritant to the hen's egg-chorioallantoic membrane test (HET-CAM test) and demonstrated significant antibacterial response in the in vitro minimum inhibitory, bactericidal, live-dead cells, zone of inhibition, and biofilm inhibition assays against the keratitis-inducing pathogen Pseudomonas aeruginosa. The antiquorum sensing activity of GC has been explored for the first time. The NPs disrupted the bacterial quorum sensing by inhibiting the production of virulence factors, including acyl homoserine lactones, pyocyanin, and motility, and caused significant downregulation of quorum sensing associated genes. In the in vivo studies, CIP@GC(PLA) NPs (1:1) displayed ocular retention in vivo (∼6 h) and decreased the opacity and the bacterial load effectively. Overall, the CIP@GC(PLA) NP (1:1) is a biofilm-disrupting antiquorum sensing treatment regimen with clinical translation potential in BK.

Keywords: Pseudomonas aeruginosa; antibacterial; bacterial keratitis; glycol chitosan; nanoparticles; quorum sensing.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacteria
  • Biofilms
  • Chickens
  • Chitosan*
  • Ciprofloxacin / pharmacology
  • Eye Infections, Bacterial*
  • Female
  • Humans
  • Keratitis*
  • Nanoparticles*
  • Polyesters / pharmacology
  • Pseudomonas aeruginosa
  • Quorum Sensing

Substances

  • Ciprofloxacin
  • glycol-chitosan
  • poly(lactide)
  • Anti-Bacterial Agents
  • Polyesters
  • Chitosan